4//SEC Filing
COOPER JOHN G 4
Accession 0001209191-17-052145
CIK 0001041024other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 6:36 PM ET
Size
5.9 KB
Accession
0001209191-17-052145
Insider Transaction Report
Form 4
COOPER JOHN G
Director
Transactions
- Award
Stock Appreciation Right
2017-09-05+23,000→ 23,000 totalExercise: $6.45Exp: 2027-09-05→ Common Stock (23,000 underlying)
Footnotes (1)
- [F1]This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, (c) the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic, or (d) immediately prior to a change in control. This grant can only be settled in cash.
Documents
Issuer
ROCKWELL MEDICAL, INC.
CIK 0001041024
Entity typeother
Related Parties
1- filerCIK 0001164287
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 6:36 PM ET
- Size
- 5.9 KB